UroGen Pharma Ltd (URGN) Insider Trading
- $541,408.92
- $9,989,929.99
- Sept. 9, 2024
- Mark Schoenberg
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 9, 2024 | Insider | 859 | $13.08 | Sell | $11,235.72 | |
Sept. 9, 2024 | General Counsel | 1,521 | $13.08 | Sell | $19,894.68 | |
June 10, 2024 | Insider | 5,153 | $13.08 | Sell | $67,401.24 | |
March 18, 2024 | Insider | 12,000 | $14.05 | Sell | $168,600.00 | |
Jan. 31, 2024 | General Counsel | 4,993 | $15.74 | Sell | $78,589.82 | |
Jan. 31, 2024 | Insider | 3,789 | $15.74 | Sell | $59,638.86 | |
Aug. 31, 2023 | General Counsel | 3,800 | $18.01 | Sell | $68,438.00 | |
Jan. 31, 2023 | Insider | 1,900 | $10.12 | Sell | $19,228.00 | |
Jan. 31, 2023 | General Counsel | 1,636 | $10.12 | Sell | $16,556.32 | |
Oct. 31, 2022 | Insider | 258 | $11.85 | Sell | $3,057.30 | |
April 30, 2022 | Insider | 254 | $6.62 | Sell | $1,681.48 | |
Jan. 31, 2022 | Insider | 1,374 | $7.58 | Sell | $10,414.92 | |
Jan. 31, 2022 | CEO | 8,195 | $7.58 | Sell | $62,118.10 | |
Jan. 31, 2022 | General Counsel | 414 | $7.58 | Sell | $3,138.12 | |
Jan. 31, 2022 | CFO | 331 | $7.58 | Sell | $2,508.98 | |
Jan. 26, 2022 | Insider | 111 | $8.09 | Sell | $897.99 | |
Jan. 4, 2022 | CEO | 46,968 | $9.15 | Sell | $429,757.20 | |
Nov. 30, 2021 | General Counsel | 3,803 | $12.03 | Sell | $45,750.09 | |
Nov. 30, 2021 | CFO | 2,587 | $12.03 | Sell | $31,121.61 | |
Nov. 18, 2021 | Insider | 160 | $13.10 | Buy | $2,096.00 | |
Nov. 1, 2021 | Insider | 258 | $17.16 | Sell | $4,427.28 | |
Oct. 27, 2021 | Insider | 107 | $16.32 | Sell | $1,746.24 | |
Aug. 2, 2021 | Insider | 243 | $15.64 | Sell | $3,800.52 | |
July 26, 2021 | Insider | 103 | $15.30 | Sell | $1,575.90 | |
May 17, 2021 | CFO | 2,500 | $15.85 | Buy | $39,625.00 | |
April 26, 2021 | Insider | 89 | $19.63 | Sell | $1,747.07 | |
Jan. 31, 2021 | Insider | 1,076 | $22.07 | Sell | $23,747.32 | |
Jan. 26, 2021 | Insider | 100 | $22.12 | Sell | $2,212.00 | |
Dec. 14, 2020 | CEO | 10,000 | $18.50 | Buy | $185,000.00 | |
Dec. 4, 2020 | Insider | 662 | $19.85 | Sell | $13,140.70 | |
Oct. 26, 2020 | Insider | 101 | $20.95 | Sell | $2,115.95 | |
Oct. 15, 2020 | CFO | 2,400 | $21.77 | Sell | $52,248.00 | |
Sept. 4, 2020 | Insider | 348 | $20.20 | Sell | $7,029.60 | |
July 27, 2020 | CFO | 141 | $23.51 | Sell | $3,314.91 | |
July 27, 2020 | Insider | 70 | $23.51 | Sell | $1,645.70 | |
June 4, 2020 | Insider | 349 | $27.51 | Sell | $9,600.99 | |
April 27, 2020 | COO | 145 | $24.35 | Sell | $3,530.75 | |
April 27, 2020 | CFO | 141 | $24.35 | Sell | $3,433.35 | |
April 27, 2020 | Insider | 70 | $24.35 | Sell | $1,704.50 | |
Feb. 14, 2020 | COO | 612 | $28.04 | Sell | $17,160.48 | |
Jan. 27, 2020 | Insider | 322 | $29.15 | Sell | $9,386.30 | |
Jan. 27, 2020 | CFO | 667 | $29.28 | Sell | $19,529.76 | |
Jan. 27, 2020 | COO | 684 | $29.26 | Sell | $20,013.84 | |
Nov. 20, 2019 | CFO | 354 | $28.41 | Sell | $10,057.14 | |
Nov. 20, 2019 | CEO | 7,470 | $28.00 | Buy | $209,160.00 | |
Nov. 19, 2019 | Insider | 1,960 | $28.17 | Buy | $55,213.20 | |
Nov. 15, 2019 | CEO | 1,548 | $26.00 | Buy | $40,248.00 | |
Nov. 14, 2019 | COO | 608 | $26.00 | Sell | $15,808.00 | |
Aug. 20, 2019 | CFO | 1,416 | $33.07 | Sell | $46,827.12 | |
Aug. 15, 2019 | COO | 608 | $31.65 | Sell | $19,243.20 |
Insiders are both buying and selling UroGen Pharma Ltd stock.
The insider traders at UroGen Pharma Ltd are: Mark Schoenberg, Stephen Mullennix, Jason Drew Smith, Peter P Pfreundschuh, Elizabeth A Barrett, Molly Henderson, and Proquest Investments Iv, L.P.
The most active insider trader at UroGen Pharma Ltd is Mark Schoenberg with 27 trades.
Proquest Investments Iv, L.P. has sold the most UroGen Pharma Ltd stock with a total value of $16,994,997.60.
Elizabeth A Barrett has bought the most UroGen Pharma Ltd stock with a total value of $619,408.00.
The most recent insider trade for UroGen Pharma Ltd was on Sept. 9, 2024.
The single biggest insider buy for UroGen Pharma Ltd was from Elizabeth A Barrett with a total value of $209,160.00 on Nov. 20, 2019.
The single biggest insider sell for UroGen Pharma Ltd was from Proquest Investments Iv, L.P. with a total value of $8,497,498.80 on Nov. 28, 2017.